at day 10 after the initiation of colitis body weight loss was significantly higher in placebo-treated mice than in bile acid-treated mice p  0.027 0.021 and 0.021 for treatment withb.c.5601 2 3 4 5 6 7 8 910510 8-5-10-15-20-25-30days432100 1 2 3 4 5 6 7 8 9p0.086420c p t u gd.5003000days400no dssdss4003002001000c p t u g200010000c p t u g3002001000c p t u gno dssdssno dssdssno dssdsse.150010003000020000  150100 50010000500c p t u g0c p t u g0c p t u gno dssdssno dssdssno dssdssfig 1 oral administration of udca tudca and gudca improves clinical parameters and inflammatory markers in acute dss-induced colitis.

10008006004002000c p t u g6543210c p t u g6050403020100c p t u gd.1.41.21.00.80.60.40.2no dssdsse.100908070605040no dssdssno dss100959085dss0.0 c p t u g3080nodss20 c p t u g dss10no dssdss0cptugunclassified bacteria candidatus saccharibacteriano dssdssdeferribacteres proteobacteria firmicutes bacteroidetesfig 2 oral administration of udca tudca and gudca during dss-induced colitis prevents colitis-associated dysbiosis at the phylum level.

p  0.05  p  0.01. c control p placebo t tudca u udca g gudca.as modulators of the intestinal microbiota   which is believed to play a critical role in colitis   we questioned whether the administration of udca or its conjugated derivatives prevented dysbiosis during experimental colitis.

p  0.05  p  0.01  p  0.001. c control p placebo t tudca u udca g gudca.from uhplc-hrms analysis.

interestingly a diet high in saturated fat promotes taurine-associated conjugation of hepatic bile acids resulting in the outgrowth of b. wadsworthia and exacerbation of colitis .considering that the gut microbial architecture and metabolism contribute to the course of ibd   we compared the therapeutic effectiveness of udca and its taurine or glycine conjugates in dss-induced colitis in mice and investigated their impact on the fecal microbial community.resultsoral administration of udca or its taurine- or glycine-conjugated species is equally protective in acute dss-induced colitis.

p  0.05  p  0.01. c control p placebo t tudca u udca g gudca.udca tudca and gudca respectively.

p  0.05  p  0.01. c control p placebo t tudca u udca g gudca.treated with udca tudca or gudca and without significant differences between the three bile acid treatments.

.laukens d devisscher l van den bossche l hindryckx p vandenb- roucke re vandewynckel y-p cuvelier c brinkman bm libert c van- denabeele p de vos m. 2014. tauroursodeoxycholic acid inhibits exper- imental colitis by preventing early intestinal epithelial cell death.

.le chatelier e nielsen t qin j prifti e hildebrand f falony g almeida m arumugam m batto j-m kennedy s leonard p li j burgdorf k grarup n jorgensen t brandslund i nielsen hb juncker as bertalan m levenez f pons n rasmussen s sunagawa s tap j tims s zoetendal eg brunak s clement k dore j kleerebezem m kristiansen k renault p sicheritz-ponten t de vos wm zucker j-d raes j hansen t metahit consortium bork p wang j ehrlich sd pedersen o.

j lipid res 231152-1158.lepercq p gerard p beguet f grill j-p relano p cayuela c juste c. 2004. isolates from normal human intestinal flora but not lactic acid bacteria exhibit 7a- and 7b-hydroxysteroid dehydrogenase activi- ties.

microbial ecologyursodeoxycholic acid and its taurine- or glycine-conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in micelien van den bosschea pieter hindryckxa lindsey devisschera sarah devriesea sophie van weldena tom holvoeta ramiro vilchez-vargasb marius vitalc dietmar h. pieperc julie vanden bussched lynn vanhaecked tom van de wieleb martine de vosa debby laukensadepartment of gastroenterology ghent university ghent belgiuma center for microbial ecology and technology ghent university ghent belgiumb microbial interactions and processes research group department of medical microbiology helmholtz centre for infection research hzi braunschweig germanyc laboratory of chemical analysis department of veterinary public health and food safety faculty of veterinary medicine ghent university ghent belgiumdabstract the promising results seen in studies of secondary bile acids in experi- mental colitis suggest that they may represent an attractive and safe class of drugs for the treatment of inflammatory bowel diseases ibd.

as expected administration of dss resulted in a significant reduction in species richness measured by the number of operational taxonomic units p  0.002  and microbial diversity shannon index which takes into account both species abundance and evenness p  0.002 .

we also thank hilde devlies griet driesschaert and petra van wassenhove for providing technical assistance.we declare no conflicts of interest.this work was supported by research grants from the research foundation flanders fwo grants 11j9915n and 1298213n a concerted action grant goa from the special research fund bof grant goa 201201g00812 of ghent university and a grant from the belgian foundation for crohn's disease and ulcerative colitis patients ccv vzw research grant 2014.referencesnagao-kitamoto h kitamoto s kuffa p kamada n. 2016. pathogenic role of the gut microbiota in gastrointestinal diseases.

.martinez-moya p romero-calvo i requena p hernandez-chirlaque c aranda cj gonzalez r zarzuelo a suarez md martinez-augustin o marin jjg de medina fs.

.rudolph g kloeters-plachky p sauer p stiehl a.

